Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study

OBJECTIVE: Prior studies identified clinical factors associated with increased risk of pancreatic ductal adenocarcinoma (PDAC). However, little is known regarding their time-varying nature, which could inform earlier diagnosis. This study assessed temporality of body mass index (BMI), blood-based ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Pui San, Garriga, Cesar, Clift, Ashley, Liao, Weiqi, Patone, Martina, Coupland, Carol, Bashford-Rogers, Rachael, Sivakumar, Shivan, Hippisley-Cox, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Pancreas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933161/
https://www.ncbi.nlm.nih.gov/pubmed/35760494
http://dx.doi.org/10.1136/gutjnl-2021-326522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933161/
https://www.ncbi.nlm.nih.gov/pubmed/35760494
http://dx.doi.org/10.1136/gutjnl-2021-326522

Ejemplares similares